Skip to content

Clinical trials

Phase 3 Ovarian Neoplasms trials in Denmark

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Phase 3 Country / region: Denmark Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20094
20101
20113
20122
20131
20153
20161
20172
20183
20192
20202
20213
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Active, not recruiting8
Recruiting4
Terminated4
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
Hoffmann-La Roche4
Merck Sharp & Dohme LLC3
Novartis Pharmaceuticals3
Tesaro, Inc.3
AGO Study Group2
Amgen2
European Organisation for Research and Treatment of Cancer - EORTC2
Nordic Society of Gynaecological Oncology - Clinical Trials Unit2
Pfizer2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms37
Fallopian Tube Neoplasms14
Carcinoma, Ovarian Epithelial9
Peritoneal Neoplasms5
Neoplasms2
Breast Neoplasms1
Endometrial Neoplasms1
Fibrosarcoma1
Genital Diseases, Female1
Hemangiosarcoma1

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.